The CRISPR-Cas9 technology is emerging as a powerful tool for gene editing in gynecology. It allows precise modifications in genes, offering potential therapeutic strategies for genetic disorders impacting female reproductive health. Research is ongoing to explore its efficacy in treating conditions such as polycystic ovary syndrome (PCOS) and hereditary breast and ovarian cancer syndrome.
